2. Technetium TC 99M Sestamibi Dosage and Administration For Myocardial Imaging:The suggested dose range for I.V. administration of Technetium Tc 99m Sestamibi in a single dose to be employed in the average patient (70 Kg) is 370–1110 MBq (10–30 mCi). For Breast Imaging:The recommended...
~(99m)Tc-Sestamibi:一种新的甲状旁腺显像剂 下载积分:4990 内容提示: 1 8 98 01肺 启息 者血浦c幻3 0洲 定的璐康研究旧〕 / 松原 羲人… 刀癌 口明床一8 9 9 1,邵 (8 ).一 1 5 5 7 份 6 5c 人 1 3 。是 ~ 种与 c A 1 2 5含有 不同 执原 决定基 的新的 肿瘤标志物。
Using 99m Tc-sestamibi to Evaluate the Effects of a Chemosensitizer on P-glycoprotein in Multidrug-Resistant Carcinoma Cells99mTc-MIBIP-糖蛋白多元抗药性肿瘤细胞乳腺肿瘤Objective: To establish a method to evaluate the effects of chemosensitizer on P-glycoprotein using ^99mTc-MIBI, and observe the ...
Tc-99m-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein Tc-99m-sestamibi (Tc-99m-MIBI) is a substrate for the P-glycoprotein (P-gp) pump but it is not known whether it is a substrate for the multidrug resistance-associated protein (MRP) pump. ...
美国FDA橙皮书数据库提供Technetium Tc 99m Sestamibi药品的详细信息,包括申请号78098,中文名称TC-99M甲氧基异丁基异睛试剂盒,商标名,剂型/给药途径,参比制剂,企业名称Curium,批准日期等信息,以及Technetium Tc 99m Sestamibi的专利和市场独占信息的查询.
②单纯PTCA术后冠脉血管再狭窄占狭窄总数 83 3% ,PTCA结合Stent支架介入治疗后血管再狭窄约占狭窄总数 16 7% ,两种方法有显著性差异 (P <0 .0 5 ) ;③以冠状动脉造影为参照 ,99mTc sestamibi运动心肌断层显像判断术后冠脉再狭窄灵敏性和特异性分别为 76 9%和 95 0 %.结论 99mTc sestamibi运动心肌灌注断层...
(redirected fromTechnetium tc 99m sestamibi) Medical ses·ta·mi·bi (sĕs′tə-mē′bē) n. An injectable drug containing an isotope of the radioactive element technetium, used in nuclear medicine imaging primarily to visualize the heart muscle, parathyroid glands, and breast tissue. ...
Whole body and SPECT Tc-99m sestamibi scintigraphy successfully identified and suggested the proliferative nature of a left frontal brain lesion and of a pulmonary tumor (low-grade adenocarcinoma) in a 74-year-old man with increased sexual activity, right-sided hemiparesis, and slight motor aphasia...
INTRODUCTION: (99m)Tc-sestamibi has been proposed as a viability imaging agent. The purposes of this study were: (1) to determine the relationship between myocardial viability and (99m)Tc-sestamibi kinetics using perfused rat heart models across a full spectrum of viability, (2) to do so un...
Tc-99m-sestamibi-SPECT/CT may be a new tool for the postoperative evaluation of regional perfusion and viability of buried perforator based free flaps. 展开 关键词: autologous breast reconstruction postoperative monitoring perforator based free flap Tc-99m-sestamibi-SPECT/CT subcutaneous fat ...